Moreover, most of the studies have demonstrated that therapeutic targeting angiogenesis such as blocking VEGF receptor (VEGFR) signalling pathway, blockade Toll‐like receptor 4 and adenovirus expressing the extracellular domain of Tie2 inhibited liver fibrosis 9, 10, 11, 12. This evidence concerns the gene KDR and Hepatic fibrosis.